Genomics of Drug Sensitivity in Cancer |
GW843682X
|
Synonyms |
GW843682X (AN-13)
|
Targets |
PLK1
|
Target pathway |
Cell cycle
|
PubCHEM ID |
9826308
|
Jsmol |
|
Download molecule |
9826308
|
PUBCHEM IUPAC INCHI |
InChI=1S/C22H18F3N3O4S/c1-30-16-7-14-15(8-17(16)31-2)28(11-27-14)19-9-18(20(33-19)21(26)29)32-10-12-5-3-4-6-13(12)22(23,24)25/h3-9,11H,10H2,1-2H3,(H2,26,29)
|
Smiles |
S2(C(=C(OCC1(=C(C=CC=C1)C(F)(F)F))C=C2N4(C3(=C(C=C(OC)C(=C3)OC)N=C4)))C(=O)N)
|
Cluster number |
65
|
calculated LogS |
-8,072
|
Molecular weight |
477,462
|
calculated LogP |
4,083
|
H-Acceptors |
7
|
H-Donors |
1
|
Ro5 violations |
0
|
Druglikeness |
-4,1472
|
DrugScore |
0,178093514732667
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Fish Toxicity |
High FHMT
|
Fish Toxicity2 |
0,9802
|
Rat Acute Toxicity |
2,3891
|
Acute Oral Toxicity |
III
|
Caco-2 Permeability |
Caco2-
|
Caco-2 Permeability2 |
1,1572
|
P-glycoprotein Substrate |
Non-substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor2 |
Inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition2 |
Inhibitor
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity2 |
0,7182
|
AMES Toxicity |
Non AMES toxic
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Inhibitor
|
CYP450 2C9 Inhibitor |
Inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Substrate |
Non-substrate
|
Biodegradation |
Not ready biodegradable
|
Carcinogenicity (Three-class) |
Non-carcinogens
|
Carcinogens |
Non-required
|
Blood-Brain Barrier |
BBB+
|
CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
Honey Bee Toxicity |
Low HBT
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Subcellular localization |
Lysosome
|
Human Intestinal Absorption |
HIA+
|
Aqueous solubility |
-4,5164
|